東方盛虹(000301.SZ):江蘇疌泉基金將向盛虹煉化增資30億元
格隆匯 11 月 13日丨東方盛虹(000301.SZ)公佈,公司的二級控股子公司盛虹煉化(連雲港)有限公司(“盛虹煉化”)擬與江蘇疌泉盛虹煉化債轉股投資基金(有限合夥)(“江蘇疌泉基金”)、江蘇盛虹石化產業發展有限公司(“石化產業”)、連雲港盛虹煉化產業基金合夥企業(有限合夥)(“連雲港產業基金”)簽訂《關於盛虹煉化(連雲港)有限公司之增資協議》。根據增資協議,江蘇疌泉基金將以每股1元人民幣的價格,向盛虹煉化增資人民幣30億元,增資款全部計入盛虹煉化實收資本。增資完成後,江蘇疌泉基金持有盛虹煉化15.7233%的股權。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.